ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1233
0,37%
Bitcoin
69.596,04
-2,60%
Brent Oil
82,405
-1,35%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Connect Biopharma Holdings Inc (CNTB)

  7. Connect Biopharma Holdings Inc (CNTB) Notícias

CNTB

Connect Biopharma (CNTB)

Connect Biopharma Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CNTB
DataHoraFonteTítuloCódigoCompanhia
27/02/202423:00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202418:30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:CNTBConnect Biopharma Holdings Inc
13/02/202418:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CNTBConnect Biopharma Holdings Inc
12/02/202418:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CNTBConnect Biopharma Holdings Inc
23/06/202317:32Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202317:59Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CNTBConnect Biopharma Holdings Inc
11/04/202317:05GlobeNewswire Inc.Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
18/03/202315:40Business WireConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient SymptomsNASDAQ:CNTBConnect Biopharma Holdings Inc
17/03/202317:05Business WireConnect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body RegionsNASDAQ:CNTBConnect Biopharma Holdings Inc
06/03/202310:15Business WireConnect Biopharma CBP-201 Atopic Dermatitis Abstracts from Two Trials Accepted for Presentation at the American Academy of Dermatology (AAD) Annual MeetingNASDAQ:CNTBConnect Biopharma Holdings Inc
14/02/202308:33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
06/02/202310:30GlobeNewswire Inc.Connect Biopharma to Present at SVB Securities Global Biopharma Conference and Participate in BioCom CaliforniaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/01/202318:32Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNTBConnect Biopharma Holdings Inc
30/12/202209:30GlobeNewswire Inc.Connect Biopharma Provides Business and Clinical Development Program UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
19/12/202210:00GlobeNewswire Inc.Connect Biopharma to Present at the San Francisco Biotech Showcase in JanuaryNASDAQ:CNTBConnect Biopharma Holdings Inc
02/12/202219:00GlobeNewswire Inc.Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price RequirementNASDAQ:CNTBConnect Biopharma Holdings Inc
27/10/202217:05GlobeNewswire Inc.Connect Biopharma To Present at Upcoming Investor and Scientific ConferencesNASDAQ:CNTBConnect Biopharma Holdings Inc
05/10/202209:45TipRanksConnect Biopharma Holdings (CNTB) Receives a Buy from JefferiesNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202209:56GlobeNewswire Inc.CORRECTING and REPLACING -- Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
04/10/202208:00GlobeNewswire Inc.Connect Biopharma Reports CBP-201 Achieved All Primary and Key Secondary Endpoints in Pivotal Atopic Dermatitis (AD) Trial in ChinaNASDAQ:CNTBConnect Biopharma Holdings Inc
03/10/202217:10GlobeNewswire Inc.Connect Biopharma to Host a Conference Call Tuesday, October 4 to Discuss Topline Results for the Pivotal Trial in China of Lead Candidate, CBP-201, in Patients with Moderate-to-Severe Atopic DermatitisNASDAQ:CNTBConnect Biopharma Holdings Inc
13/09/202217:05GlobeNewswire Inc.Connect Biopharma Reports First Half 2022 Financial Results and Provides Business UpdateNASDAQ:CNTBConnect Biopharma Holdings Inc
01/09/202209:00GlobeNewswire Inc.Connect Biopharma to Report First Half 2022 Financial Results on September 13NASDAQ:CNTBConnect Biopharma Holdings Inc
30/08/202209:00GlobeNewswire Inc.Connect BioPharma Successfully Completes CBP-174 Phase 1 Single Ascending Dose StudyNASDAQ:CNTBConnect Biopharma Holdings Inc
14/07/202203:18TipRanksSVB Securities Thinks Connect Biopharma Holdings’ Stock is Going to RecoverNASDAQ:CNTBConnect Biopharma Holdings Inc
11/07/202217:05GlobeNewswire Inc.Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022NASDAQ:CNTBConnect Biopharma Holdings Inc
07/07/202207:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNTBConnect Biopharma Holdings Inc
01/07/202218:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CNTBConnect Biopharma Holdings Inc
02/06/202217:05GlobeNewswire Inc.Connect Biopharma to Participate at the Jefferies Healthcare ConferenceNASDAQ:CNTBConnect Biopharma Holdings Inc
23/05/202207:02Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3/a)NASDAQ:CNTBConnect Biopharma Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CNTB

Seu Histórico Recente

USOTC
ALGCF
Allegiance Coal (PK)
LSE
TMTA
Tmt Acquisition
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados